The global market for Artificial Intelligence in Drug Discovery is predicted to experience significant growth in the coming years. According to a recent report, the market was valued at US$ 1,016.1 million in 2024 and is expected to reach US$ 3,547.4 million by 2031, showing a compound annual growth rate (CAGR) of 5.7% between 2024 and 2031.
The report provides a detailed analysis of the market, covering aspects such as product pricing, market dynamics, key players, consumer behavior, and more. It also explores the opportunities available in the market at both the country and global levels.
Key players in the Artificial Intelligence in Drug Discovery Market include IBM Corporation, Exscientia, Alphabet Inc., and others. The report segments the market based on therapeutic space (such as oncology, neurodegenerative diseases, and cardiovascular diseases) and their applications (drug optimization & repurposing, preclinical testing, etc.).
Geographically, the market is divided into regions like North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The report also highlights the market’s competitive landscape, including the strengths, weaknesses, opportunities, and threats for the major players.
Overall, the report offers valuable insights into the market trends, growth drivers, and challenges, providing a comprehensive understanding of the Artificial Intelligence in Drug Discovery Market for the forecast period from 2024 to 2031.
